The authors observed two-way SNP–SNP interactions (APEX1-rs1130409 and RPAP1-rs2297381; MLH1-rs1799977 and MDM2-rs769412) that conferred elevated risks for BC (p (interaction) < 7.3 × 10−3) [71]. This evidence concerns the gene MLH1 and breast cancer.